Abstract
Infection of a tumor cell with a replication-competent virus, can result in the destruction of the tumor, but spares the neighboring normal cells; this is a new tool to treat cancer. These viruses are modified to specifically target cancer cells. In addition, this can lead to induction of host immune response to tumor cell antigens.
We will consider articles highlighting the full breadth of scientific findings in the form of original research papers and reviews.
Areas of interest include, but are not limited to: Review of Viral Oncolysis Mechanisms of Resistance of tumors to Viral Oncolysis Treatment of solid and circulating tumors Markers of clinical efficacy of treatment New candidate viruses for viral oncolysis Checkpoint inhibitors and viral oncolysis Veterinary applications of viral oncolysis Adjuvant therapy and viral oncolysis
In vivo studies Clinical trials Genetic variation among viruses used in oncolysis applications
Contributions will receive prompt and thorough peer review. Please refer to our Instructions for Authors before submitting your manuscript for consideration. Authors are encouraged to vet ideas directly with Carol Shoshkes Reiss, our editor-in-chief, and Janaina Fernandes, the guest editor of the Special Focus issue via e-mail before submitting. Instructions for Authors can be found on our website at
Janaina Fernandes, Guest Editor,
Carol Shoshkes Reiss, Editor-in-Chief,